Radiation does not improve survival for rare, invasive bladder cancer

	Tweet

In the largest study to date of a rare and deadly form of bladder cancer, researchers at Henry Ford Hospital in Detroit found radiation therapy may not improve a patient’s chances for survival.

While overall survival for adenocarcinoma of the bladder was poor, the study revealed several factors that may improve a patient’s prognosis, including being diagnosed at age 60 or younger, and having cystectomy, a procedure that either removes all or a portion of the bladder.

“While this malignancy afflicts just one to two percent of people diagnosed with bladder cancer, chances of surviving it for five years are grim – only 18 percent – in part because it is usually detected at an advanced stage,” says study lead author Naveen Pokala, M.D., an urologist at Henry Ford Hospital. 

"By the time the primary cancer is found, it may already have penetrated all four walls of the bladder and spread to adjacent organs and beyond, including the peritoneum, lymph nodes, and lungs.”

The study will be presented June 2 at the 2010 American Urology Association’s annual meeting in San Francisco.

In 2009, the National Cancer Institute estimated 70,980 new cases of bladder cancer were diagnosed in the U.S., while 14,330 died of the disease. According to the American Cancer Society, only about 1 percent of bladder cancers are adenocarcinomas. It invades the mucous cells in the bladder lining, and is the result of chronic irritation and inflammation. Nearly all adenocarcinomas of the bladder are invasive.

For their study, researchers at Henry Ford Hospital studied more than 850 patients with adenocarcinoma of the bladder, all selected from the National SEER database.

Of the study group, 96 patients had had a partial cystectomy; 164 had a total cystectomy; 375 had an endoscopy procedure; and 202 had an unspecified surgery. Among this group, some patients were treated with radiation therapy.

The population-based study had a mean age of 66.9 years among 514 males and 338 women; 707 were white, 94 African American, and 51 other races.

Race, the year of diagnosis, and radiation therapy did not affect survival.

Their overall survival rate was poor. The factors found in better prognoses were age 60 or younger; a well-differentiated, localized tumor in the dome (top) of the bladder, or the urachus, a vestigial cord that once connected the fetal bladder and contributed to development of the umbilical cord; and a total or partial cystectomy.

###

In addition to Dr. Pokala, study co-authors at Henry Ford Hospital included James Peabody, M.D.; Hans Stricker, M.D.; Piyush Agarwal, M.D.; and Mani Menon, M.D.

---

Contact: Krista Hopson

313-874-7207
Henry Ford Health System

RELATED STORIES:
Patients unaware of link between smoking and bladder cancer   Gene test shows which bladder cancer patients may have cancer spread   Bladder cancer: A difficult problem?   UT Southwestern researchers investigate high-risk populations for bladder-cancer screenings   New made-in-Canada therapy for bladder cancer shows promising results   Estrogen use tied to bladder control problems   Urinary tract cancer associated with Chinese herbal products containing aristolochic acid   Nearly all patients with high-grade bladder cancer do not receive guideline-recommended care   The Predictors of Local Recurrence After Radical Cystectomy in Patients with Invasive Bladder Cancer   Not enough evidence for bladder cancer screening   Measurement of Urinary Protein Can Help Detect Recurrent Bladder Cancer   Bladder cancer patients rarely receive recommended care   Researcher Says Improved Detection of Bladder Tumors Reduces Cancer Recurrence   Thomas Jefferson University Hospital adopts new imaging agent to improve detection of bladder cancer   Meat, Especially If It’s Well Done, May Increase Risk of Bladder Cancer   Consumption of Cultured Milk Products May Reduce Bladder Cancer Risk   New Trial Targets Kidney Cancer Drug in Bladder Cancer   More Intense Bladder Cancer Treatment Does Not Improve Survival   Blood test may find markers of bladder cancer risk   Brochure Helps Patients Understand Treatments for Bladder Cancer   Sales jobs tied to bladder cancer risk   Bladder Cancer Study Determines Optimal Treatment

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]